<p><strong>National Vision Holdings Inc</strong> (NASDAQ: EYE) 于周三发布了混合的第一季度财务 结果。</p>
<p>National Vision 报告的季度每股收益为 45 美分，超出分析师一致预期的 43 美分。公司报告的季度销售额为 5.439 亿美元，未能达到分析师一致预期的 5.45173 亿美元。</p>
<p>National Vision Holdings 确认 2026 财年的调整后每股收益指引为 0.85-1.09 美元，销售指引为 20.33 亿-20.91 亿美元。</p>
<p>National Vision 的首席执行官 Alex Wilkes 表示：“我们交出了一个稳健的第一季度，进一步证明我们在投资者日提出的转型正在转化为更高质量的增长和改善的盈利能力。客户继续选择更好的产品，我们扩大了管理医疗业务，并通过严格的费用管理显著提高了运营利润率。我们相信，在商品和店内体验方面的进展正在巩固我们作为光学类别价值目的地的地位——为每位客户提供卓越的品牌产品和无妥协的眼科检查。”</p>
<p>National Vision 的股票在周四上涨 2.3%，交易价格为 17.32 美元。</p>
<p>这些分析师在盈利公告后对 National Vision 的目标价格进行了调整。</p>
<ul>
<li>美国银行证券分析师 Robert Ohmes 维持该股票的买入评级，并将目标价格从 35 美元下调至 30 美元。</li>
<li>巴克莱分析师 Adrienne Yih 维持该股票的超配评级，并将目标价格从 38 美元下调至 27 美元。</li>
<li>富国银行分析师 Zachary Fadem 维持 National Vision Holdings 的平衡评级，并将目标价格从 30 美元下调至 20 美元。</li>
</ul>
<p><strong>考虑购买 EYE 股票吗？以下是分析师的看法：</strong></p>
<p></p>
<p><em>照片来源于 Shutterstock</em></p>

<p>National Vision Holdings Inc (EYE) 发布了喜忧参半的第一季度业绩，盈利每股 45 美分超出预期，但销售额 5.439 亿美元未能达到预期。分析师们下调了他们的目标价，BofA 证券将目标价从 35 美元下调至 30 美元，巴克莱将目标价从 38 美元下调至 27 美元，富国银行则将目标价从 30 美元下调至 20 美元。尽管业绩喜忧参半，股价仍上涨 2.3%，至 17.32 美元。首席执行官 Alex Wilkes 强调了公司对高质量增长和改善盈利能力的关注</p>

<p><strong>National Vision Holdings Inc</strong> (NASDAQ: EYE) reported mixed first-quarter financial results on Wednesday.</p>
<div class="lb-trans"><p><strong>National Vision Holdings Inc</strong> (NASDAQ: EYE) 于周三发布了混合的第一季度财务 结果。</p>
</div><p>National Vision reported quarterly earnings of 45 cents per share which beat the analyst consensus estimate of 43 cents per share. The company reported quarterly sales of $543.900 million which missed the analyst consensus estimate of $545.173 million.</p>
<div class="lb-trans"><p>National Vision 报告的季度每股收益为 45 美分，超出分析师一致预期的 43 美分。公司报告的季度销售额为 5.439 亿美元，未能达到分析师一致预期的 5.45173 亿美元。</p>
</div><p>National Vision Holdings affirmed FY2026 adjusted EPS guidance of $0.85-$1.09 and sales guidance of $2.033 billion-$2.091 billion.</p>
<div class="lb-trans"><p>National Vision Holdings 确认 2026 财年的调整后每股收益指引为 0.85-1.09 美元，销售指引为 20.33 亿-20.91 亿美元。</p>
</div><p>Alex Wilkes, National Vision’s CEO, said, “We delivered a solid first quarter, reinforcing that the transformation we laid out at Investor Day is translating into higher-quality growth and improved profitability. Customers continued to opt into better products, we expanded our managed care business, and we meaningfully grew operating margins through disciplined expense management. We believe our advancements across merchandising and store experience are strengthening our position as the destination for value in the optical category – delivering great branded products and leading eye exams without compromise, for every customer.”</p>
<div class="lb-trans"><p>National Vision 的首席执行官 Alex Wilkes 表示：“我们交出了一个稳健的第一季度，进一步证明我们在投资者日提出的转型正在转化为更高质量的增长和改善的盈利能力。客户继续选择更好的产品，我们扩大了管理医疗业务，并通过严格的费用管理显著提高了运营利润率。我们相信，在商品和店内体验方面的进展正在巩固我们作为光学类别价值目的地的地位——为每位客户提供卓越的品牌产品和无妥协的眼科检查。”</p>
</div><p>National Vision shares gained 2.3% to trade at $17.32 on Thursday.</p>
<div class="lb-trans"><p>National Vision 的股票在周四上涨 2.3%，交易价格为 17.32 美元。</p>
</div><p>These analysts made changes to their price targets on National Vision following earnings announcement.</p>
<div class="lb-trans"><p>这些分析师在盈利公告后对 National Vision 的目标价格进行了调整。</p>
</div><ul>
<li>B of A Securities analyst Robert Ohmes maintained the stock with a Buy and lowered the price target from $35 to $30.</li>
<li>Barclays analyst Adrienne Yih maintained the stock with an Overweight rating and lowered the price target from $38 to $27.</li>
<li>Wells Fargo analyst Zachary Fadem maintained National Vision Holdings with an Equal-Weight rating and cut the price target from $30 to $20.</li>
</ul>
<div class="lb-trans"><ul>
<li>美国银行证券分析师 Robert Ohmes 维持该股票的买入评级，并将目标价格从 35 美元下调至 30 美元。</li>
<li>巴克莱分析师 Adrienne Yih 维持该股票的超配评级，并将目标价格从 38 美元下调至 27 美元。</li>
<li>富国银行分析师 Zachary Fadem 维持 National Vision Holdings 的平衡评级，并将目标价格从 30 美元下调至 20 美元。</li>
</ul>
</div><p><strong>Considering buying EYE stock? Here’s what analysts think:</strong></p>
<div class="lb-trans"><p><strong>考虑购买 EYE 股票吗？以下是分析师的看法：</strong></p>
</div><p></p>
<div class="lb-trans"><p></p>
</div><p><em>Photo via Shutterstock</em></p>
<div class="lb-trans"><p><em>照片来源于 Shutterstock</em></p>
</div>

National Vision Analysts Slash Their Forecasts Following Q1 Earnings

benzinga_article

National Vision

美国银行

巴克莱银行

富国银行

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

在第一季度财报公布后，National Vision 的分析师大幅下调了他们的预测